Exchange: NASDAQ·Updated 07:46 PM EDT
ESLA logo

ESLA Estrella Biopharma Inc

$0.41
$0.0075
(1.80%)
Today
Closed $0.41
$0.0699
(17.05%)
After Hours
Mkt Cap$18.16M
Vol19.85M

About ESLA

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
74

Bullish Sentiment

How do you feel about ESLA?

Advertisement|Remove ads.